Skip to news
JQJO
Latest

FDA turmoil after top drug regulator resigns | JQJO

FDA turmoil after top drug regulator resigns

FDA turmoil after top drug regulator resigns

Tap title to read story

0:00 / 0:38

The FDA is roiled by the resignation of George Tidmarsh, former head of the Center for Drug Evaluation and Research, after a lawsuit by Aurinia Pharmaceuticals alleged he defamed its lupus nephritis drug on LinkedIn, spurring a 20 percent stock drop, and sought revenge against board chair Kevin Tang—claims he denies. Tidmarsh had faced criticism for moving away from expert advisory meetings. Axios described staff texts showing dismay and rising attrition fears. An FDA spokesperson said he was placed on administrative leave over serious personal conduct concerns before he quit.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

More context

Sources

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Chalamet Declines Call Me By Your

Tap title to read story

0:00 / 0:00

JQJO

Find your next story

Search JQJO’s current coverage.